Trinity Biotech (TRIB) Capital Expenditures (2009 - 2024)
Trinity Biotech recorded quarterly Capital Expenditures of -$157000.0 in Q4 2024, up 37.2% quarter-over-quarter from -$250000.0 in Q4 2023, and up 37.2% year-over-year from -$114431.5 in Q1 2024.
Trinity Biotech's Capital Expenditures history runs 6 years deep, the most recent figure standing at -$157000.0 for Q4 2024.
- In Q4 2024, Capital Expenditures rose 37.2% year-over-year to -$157000.0; the TTM figure through Dec 2024 stood at -$1.0 million (up 13.97% YoY), while the FY2025 annual figure was $88000.0, down 78.27% from the prior year.
- Capital Expenditures came in at -$157000.0 for Q4 2024 at Trinity Biotech, up from -$250000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$143.0 in Q2 2022 to a low of -$570000.0 in Q4 2021.
- A 4-year average of -$237691.5 and a median of -$203500.0 in 2023 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 63.24% in 2022 and fell as far as 16.67% in 2022.
- Trinity Biotech's Capital Expenditures stood at -$570000.0 in 2021, then increased by 16.67% to -$475000.0 in 2022, then soared by 47.37% to -$250000.0 in 2023, then soared by 37.2% to -$157000.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$157000.0, -$250000.0, and -$128000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -157,000.00 |
| Dec 31, 2024 | -157,000.00 |
| Dec 31, 2023 | -250,000.00 |
| Dec 31, 2023 | -250,000.00 |
| Sep 30, 2023 | -128,000.00 |
| Sep 30, 2023 | -128,000.00 |
| Dec 31, 2022 | -475,000.00 |
| Dec 31, 2022 | -475,000.00 |
| Sep 30, 2022 | -321,000.00 |
| Sep 30, 2022 | -321,000.00 |
| Jun 30, 2022 | -143.00 |
| Jun 30, 2022 | -143.00 |
| Dec 31, 2021 | -570,000.00 |
| Dec 31, 2021 | -570,000.00 |
| Jun 30, 2021 | -389.00 |
| Jun 30, 2021 | -389.00 |
| Sep 30, 2010 | -1.52 Mn |
| Sep 30, 2010 | -1.52 Mn |
| Jun 30, 2010 | -1.11 Mn |
| Jun 30, 2010 | -1.11 Mn |
| Mar 31, 2010 | -2.32 Mn |
| Mar 31, 2010 | -2.32 Mn |
| Dec 31, 2009 | -2.39 Mn |
| Dec 31, 2009 | -2.39 Mn |
| Sep 30, 2009 | -1.60 Mn |
| Sep 30, 2009 | -1.60 Mn |
| Jun 30, 2009 | -1.89 Mn |
| Jun 30, 2009 | -1.89 Mn |
| Mar 31, 2009 | -2.50 Mn |
| Mar 31, 2009 | -2.50 Mn |